Who owns the BIOSPLICE trademark?

The BIOSPLICE trademark is owned by Biosplice Therapeutics, Inc..

What is the serial number for BIOSPLICE?

The USPTO serial number for BIOSPLICE is 90852803.

What is the registration number for BIOSPLICE?

BIOSPLICE is registered under USPTO registration number 0.

BIO

USPTO Trademark Record

PENDING

BIOSPLICE

Q: What class is the BIOSPLICE trademark registered in?

The BIOSPLICE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 90852803·Reg 0·Filed Jul 28, 2021

Owner Biosplice Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

BIOSPLICE (Serial No. 90852803), Registration No. 0, is a pending US trademark filed on Jul 28, 2021 by Biosplice Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

BIOSPLICE (Reg. #0) is a pending US trademark that was filed in 2021 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 28, 2021

SERIAL

90852803

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Biosplice Therapeutics, Inc.

Entity

Corporation

State

Address

9360 Towne Centre Drive, San Diego, CA, 92121

Country

Attorney

NameSARAH B. KELLEHER

Law firm

SARAH B. KELLEHER FISH & RICHARDSON PC

Docket

291240158001

Address

PO BOX 1022, MINNEAPOLIS, MN 55402, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateJul 28, 2021

Serial Number90852803

Registration No.0

Registration DateDec 31, 1969

Status DateFeb 25, 2026

Published for OppositionApr 15, 2025

Mark TypeDesign with words

Attorney Docket291240158001

Status DescriptionLive and pending, statement of use sent to examiner

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Apr 30, 2021

First use in commerce: Apr 30, 2021

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Apr 30, 2021

First use in commerce: Apr 30, 2021

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

40 events

STATEMENT OF USE PROCESSING COMPLETE

Feb 25, 2026

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 24, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Aug 19, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Aug 19, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 10, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 15, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 15, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 09, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXPARTE APPEAL DISMISSED AS MOOT

Mar 25, 2025

EXPARTE APPEAL DISMISSED AS MOOT

EXPARTE APPEAL TERMINATED

Mar 25, 2025

EXPARTE APPEAL TERMINATED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 20, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 01, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 29, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 29, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Nov 29, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 29, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 29, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

JURISDICTION RESTORED TO EXAMINING ATTORNEY

Oct 11, 2023

JURISDICTION RESTORED TO EXAMINING ATTORNEY

EXPARTE APPEAL RECEIVED AT TTAB

Oct 11, 2023

EXPARTE APPEAL RECEIVED AT TTAB

EX PARTE APPEAL-INSTITUTED

Oct 11, 2023

EX PARTE APPEAL-INSTITUTED

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Oct 11, 2023

TEAS REQUEST FOR RECONSIDERATION RECEIVED

FINAL REFUSAL WRITTEN

Jul 11, 2023

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Jul 11, 2023

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Jul 11, 2023

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 30, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 30, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 30, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Nov 29, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 29, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 29, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 28, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 27, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 27, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Apr 27, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 27, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 27, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Apr 25, 2022

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Sep 28, 2021

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 25, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 31, 2021

NEW APPLICATION ENTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

BIO

BIOSPLICE

90852797

Biosplice Therapeutics, Inc.

PENDING

BIOSPLICE

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Biosplice Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by SARAH B. KELLEHER

Resources

Company